Hemp Lawyer: FDA CBD Warning Letters Shouldn't Alarm Industry
FDA last week reminded four companies that it won’t tolerate claims that CBD-containing foods and dietary supplements treat diseases such as cancer, highlighting the potential perils of sharing consumer testimonials. The warning letters also reinforced FDA’s view that CBD (cannabidiol) cannot be sold in dietary supplements, or added to food, under the Federal Food, Drug and Cosmetic Act (FD&C).
Commenting on the 2017 warning letters, hemp attorney Garrett Graff said, “The industry should not be alarmed…Many of the positions and much of the rhetoric by the FDA is not new."
To the extent companies in the hemp industry have made claims of treating diseases, “[W]e need to look at ourselves and make sure that we’re complying with FDA regulations just like every other product line within the nutraceutical space," said Graff, an associate attorney at Hoban Law Group, in a phone interview.